Correction: Field, M. et al. AbobotulinumtoxinA (Dysport®), OnabotulinumtoxinA (Botox®), and IncobotulinumtoxinA (Xeomin®) Neurotoxin Content and Potential Implications for Duration of Response in Patients

The authors wish to make the following corrections to their paper [...]

Bibliographic Details
Main Authors:	Malgorzata Field, Andrew Splevins, Philippe Picaut, Marcel van der Schans, Jan Langenberg, Daan Noort, Daniel Snyder, Keith Foster
Format:	Article
Language:	English
Published:	MDPI AG 2019-02-01
Series:	Toxins
Subjects:	n/a
Online Access:	https://www.mdpi.com/2072-6651/11/2/115

id	doaj-54ff8dec90d54a75b15a532230bac018
record_format	Article
spelling	doaj-54ff8dec90d54a75b15a532230bac0182020-11-25T01:30:13ZengMDPI AGToxins2072-66512019-02-0111211510.3390/toxins11020115toxins11020115Correction: Field, M. et al. AbobotulinumtoxinA (Dysport<sup>®</sup>), OnabotulinumtoxinA (Botox<sup>®</sup>), and IncobotulinumtoxinA (Xeomin<sup>®</sup>) Neurotoxin Content and Potential Implications for Duration of Response in PatientsMalgorzata Field0Andrew Splevins1Philippe Picaut2Marcel van der Schans3Jan Langenberg4Daan Noort5Daniel Snyder6Keith Foster7Ipsen Bioinnovation, Abingdon OX14 4RY, UKIpsen Bioinnovation, Abingdon OX14 4RY, UKIpsen Pharma, Cambridge, MA 02142, USATNO—CBRN Protection, 2288GJ Rijswijk, The NetherlandsTNO—CBRN Protection, 2288GJ Rijswijk, The NetherlandsTNO—CBRN Protection, 2288GJ Rijswijk, The NetherlandsIpsen Biopharmaceuticals, Basking Ridge, NJ 07920, USAIpsen Bioinnovation, Abingdon OX14 4RY, UKThe authors wish to make the following corrections to their paper [...]https://www.mdpi.com/2072-6651/11/2/115n/a
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Malgorzata Field Andrew Splevins Philippe Picaut Marcel van der Schans Jan Langenberg Daan Noort Daniel Snyder Keith Foster
spellingShingle	Malgorzata Field Andrew Splevins Philippe Picaut Marcel van der Schans Jan Langenberg Daan Noort Daniel Snyder Keith Foster Correction: Field, M. et al. AbobotulinumtoxinA (Dysport<sup>®</sup>), OnabotulinumtoxinA (Botox<sup>®</sup>), and IncobotulinumtoxinA (Xeomin<sup>®</sup>) Neurotoxin Content and Potential Implications for Duration of Response in Patients Toxins n/a
author_facet	Malgorzata Field Andrew Splevins Philippe Picaut Marcel van der Schans Jan Langenberg Daan Noort Daniel Snyder Keith Foster
author_sort	Malgorzata Field
title	Correction: Field, M. et al. AbobotulinumtoxinA (Dysport<sup>®</sup>), OnabotulinumtoxinA (Botox<sup>®</sup>), and IncobotulinumtoxinA (Xeomin<sup>®</sup>) Neurotoxin Content and Potential Implications for Duration of Response in Patients
title_short	Correction: Field, M. et al. AbobotulinumtoxinA (Dysport<sup>®</sup>), OnabotulinumtoxinA (Botox<sup>®</sup>), and IncobotulinumtoxinA (Xeomin<sup>®</sup>) Neurotoxin Content and Potential Implications for Duration of Response in Patients
title_full	Correction: Field, M. et al. AbobotulinumtoxinA (Dysport<sup>®</sup>), OnabotulinumtoxinA (Botox<sup>®</sup>), and IncobotulinumtoxinA (Xeomin<sup>®</sup>) Neurotoxin Content and Potential Implications for Duration of Response in Patients
title_fullStr	Correction: Field, M. et al. AbobotulinumtoxinA (Dysport<sup>®</sup>), OnabotulinumtoxinA (Botox<sup>®</sup>), and IncobotulinumtoxinA (Xeomin<sup>®</sup>) Neurotoxin Content and Potential Implications for Duration of Response in Patients
title_full_unstemmed	Correction: Field, M. et al. AbobotulinumtoxinA (Dysport<sup>®</sup>), OnabotulinumtoxinA (Botox<sup>®</sup>), and IncobotulinumtoxinA (Xeomin<sup>®</sup>) Neurotoxin Content and Potential Implications for Duration of Response in Patients
title_sort	correction: field, m. et al. abobotulinumtoxina (dysport<sup>®</sup>), onabotulinumtoxina (botox<sup>®</sup>), and incobotulinumtoxina (xeomin<sup>®</sup>) neurotoxin content and potential implications for duration of response in patients
publisher	MDPI AG
series	Toxins
issn	2072-6651
publishDate	2019-02-01
description	The authors wish to make the following corrections to their paper [...]
topic	n/a
url	https://www.mdpi.com/2072-6651/11/2/115
work_keys_str_mv	AT malgorzatafield correctionfieldmetalabobotulinumtoxinadysportsupsuponabotulinumtoxinabotoxsupsupandincobotulinumtoxinaxeominsupsupneurotoxincontentandpotentialimplicationsfordurationofresponseinpatients AT andrewsplevins correctionfieldmetalabobotulinumtoxinadysportsupsuponabotulinumtoxinabotoxsupsupandincobotulinumtoxinaxeominsupsupneurotoxincontentandpotentialimplicationsfordurationofresponseinpatients AT philippepicaut correctionfieldmetalabobotulinumtoxinadysportsupsuponabotulinumtoxinabotoxsupsupandincobotulinumtoxinaxeominsupsupneurotoxincontentandpotentialimplicationsfordurationofresponseinpatients AT marcelvanderschans correctionfieldmetalabobotulinumtoxinadysportsupsuponabotulinumtoxinabotoxsupsupandincobotulinumtoxinaxeominsupsupneurotoxincontentandpotentialimplicationsfordurationofresponseinpatients AT janlangenberg correctionfieldmetalabobotulinumtoxinadysportsupsuponabotulinumtoxinabotoxsupsupandincobotulinumtoxinaxeominsupsupneurotoxincontentandpotentialimplicationsfordurationofresponseinpatients AT daannoort correctionfieldmetalabobotulinumtoxinadysportsupsuponabotulinumtoxinabotoxsupsupandincobotulinumtoxinaxeominsupsupneurotoxincontentandpotentialimplicationsfordurationofresponseinpatients AT danielsnyder correctionfieldmetalabobotulinumtoxinadysportsupsuponabotulinumtoxinabotoxsupsupandincobotulinumtoxinaxeominsupsupneurotoxincontentandpotentialimplicationsfordurationofresponseinpatients AT keithfoster correctionfieldmetalabobotulinumtoxinadysportsupsuponabotulinumtoxinabotoxsupsupandincobotulinumtoxinaxeominsupsupneurotoxincontentandpotentialimplicationsfordurationofresponseinpatients
_version_	1725092880725311488

Correction: Field, M. et al. AbobotulinumtoxinA (Dysport<sup>®</sup>), OnabotulinumtoxinA (Botox<sup>®</sup>), and IncobotulinumtoxinA (Xeomin<sup>®</sup>) Neurotoxin Content and Potential Implications for Duration of Response in Patients

Similar Items